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PURPOSE: To determine whether patients with male factor infertility can be accurately identified by calculating a novel
semen quality score and measuring levels of reactive oxygen species during routine infertility screening.
METHODS: Semen samples from 133 patients and 91 healthy donors were evaluated with manual and computer-assisted
semen analysis. A principal component analysis model was employed to calculate a semen quality score. In brief, this score
was calculated by base 10 logarithms multiplied by varying weights given to 9 sperm parameters. Reactive oxygen species
levels were measured using chemiluminescence assay.
RESULTS: The semen quality score had a sensitivity of 80.45% and accuracy of 77% at a cutoff of 93.1 in identifying
patients with male factor infertility. The area under the receiver operating characteristic curves for the semen quality score
was 84.28% (95% CI: 65.22%-100%). Reactive oxygen species levels [log10 (reactive oxygen species +1)] were significantly
higher in male factor infertility patients. Reactive oxygen species had a sensitivity of 83.47% and specificity of 60.52%
with an accuracy of 75% at a cutoff of 1.25 in identifying male factor infertility patients. The area under the receiver
operating characteristic curve for reactive oxygen species levels was 78.92% (95% CI: 72.60%-85.23%). semen quality
scores were significantly and negatively correlated with reactive oxygen species levels in the donors and the male factor
infertility patients.
CONCLUSIONS: The semen quality score and reactive oxygen species levels in semen samples appear to be strongly
associated with male factor infertility. Because both of these parameters are more sensitive than individual sperm parameters
in identifying male factor infertility, they should be included in routine infertility screening.
KEYWORDS: Spermatozoa. Male factor infertility. Semen quality score. Reactive oxygen species. Sperm parameters.
Infertility affects an estimated 10% to 15% of couples,
and in approximately half of these cases, the defect can be
traced to the man.1 Although considerable progress has been
made towards understanding sperm physiology and the bi-
ology of gamete interaction, more information is needed
to determine which tests, if any, can accurately predict
sperm quality.
Semen analysis remains the most important clinical labo-
ratory test available for the evaluation of male infertility.2
It is clear that both sperm concentration and the number of
motile and morphologically normal spermatozoa are sig-
nificant factors influencing in vivo and in vitro fertiliza-
tion.3-5 In addition, studies have suggested that computer-
assisted semen analysis (CASA) can precisely and reliably
estimate sperm kinematics, which in turn, significantly re-
late to the fertilization rate in vitro and the time to concep-
tion.6-9
Although semen analysis constitutes an essential com-
ponent of infertility evaluation, it may still fail to detect
subtle sperm defects present in patients with male factor in-
fertility (MFI). Although estimates vary, the likelihood for
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normal spermiograms in these cases is approximately 15%.10
Identifying diagnostic measures for MFI that are easy to per-
form, relatively inexpensive, and able to provide an accu-
rate diagnosis is necessary.
Because semen parameters are interrelated, they can be
reduced to 2 semen scores termed the overall semen qual-
ity (SQ) and relative quality (RQ) scores.11 The SQ score
was developed by principal component analysis of 9 indi-
vidual sperm parameters, and has been reported as a highly
reliable and efficient tool for clinicians who screen for and
diagnose MFI.11
Furthermore, studies have shown that 40% to 88% of
nonselected infertile patients have high levels of seminal
reactive oxygen species (ROS).12 Uncontrolled and exces-
sive production of ROS may be one of the major factors
leading to infertility.12-16 It appears, therefore, that the pres-
ence of oxidative stress in infertile normozoospermic men
may help explain previously unexplained cases of infertil-
ity that were otherwise attributed to female factors.17
The purpose of this study was to: 1) examine improved
parameters in identification of MFI patients during infer-
tility screening, 2) establish cutoff values for the SQ score
and ROS levels that identify patients with MFI, and 3) de-
termine the relationship between the SQ score and levels
of ROS in patients with MFI.
METHODS
The Institutional Review Board of The Cleveland Clinic
Foundation approved the study. Medical charts of the pa-
tients attending the infertility clinic for infertility evalua-
tion were reviewed.
Study population
The patient population consisted of 133 MFI patients.
All patients had a history of at least 1 year of primary or
secondary infertility with their current partner and had com-
pleted a basic evaluation that included medical history, a
physical examination, and at least 2 semen analyses. On
occasion, the patient provided more than 1 semen sample.
Semen samples (n = 264) were divided into 4 groups based
on results from all semen analyses: oligozoospermic (n =
61), asthenozoospermic (n = 96), teratozoospermic (n = 69),
and oligoasthenoteratozoospermic (OAT, n = 38).2 Subjects
with semen samples containing >1 x 106 round cells/mL
were excluded to avoid a potential source of ROS genera-
tion. All female partners had patent fallopian tubes and ex-
perienced regular ovulation. In addition, results of semen
samples from 91 normal healthy volunteers (donors) were
used as the control for this study.
Semen analysis
Semen was collected by masturbation after 2 to 3 days
of sexual abstinence. After liquefaction, semen analysis
was performed both manually and by computerized semen
analysis (CASA) (IVOS, 10.7s, Hamilton Thorne Research,
Beverly, MA). For each measurement, a 5 µL aliquot from
either a control or infertile patient sample was loaded on
a MicroCell slide (Conception Technologies, San Diego,
CA). Sperm motion kinetics measured by CASA included:
sperm concentration (106/mL), percent motility, curvilin-
ear velocity (VCL; µm/sec), straight-line velocity (VSL;
µm/sec), average path velocity (VAP; µm/sec), linearity
(LIN; percent), and amplitude of lateral head displacement
(ALH; µm). In addition to the computerized results,
manual results were also calculated for sperm concentra-
tion and motility.
For morphological evaluation, seminal smears were
stained with Giemsa stain (Diff-Quik, Baxter Healthcare
Corporation, McGraw Park, IL), and the percent sperm with
normal morphology was assessed by WHO guidelines2 and
Kruger’s strict criteria.18
Measurement of Reactive Oxygen Species
Aliquots of liquefied semen were centrifuged at 300x g
for 7 minutes. The sperm pellet was washed twice with phos-
phate buffered saline (PBS), pH 7.4, and resuspended in the
same medium at a concentration of 20 x 106 sperm/mL. ROS
production was measured by the chemiluminescence assay
method using luminol (5-amino-2, 3-dihydro 1, 4-
phthalazinedione; Sigma Chemical Co., St. Louis, MO) as
the probe. Ten mL of 5 mM luminol prepared in dimethyl
sulfoxide (DMSO; Sigma Chemical Co.) was added to 400
mL of the washed sperm suspension. The ROS levels were
determined by measuring chemiluminescence with a
luminometer (Autolumat LB 953, Berthold technologies,
Bad-Wildbad, Germany) in the integrated mode for 15 min-
utes. Results were expressed as 104 counted photons per
minute (cpm)/20 x 106 sperm. These were log transformed
[log (ROS + 1)], hereafter referred as ROS for simplicity, and
were used in statistical analysis.
Statistical Analysis
A principal component analysis model was employed
to calculate an overall SQ score that accounts for most of
variability observed among the battery of interrelated se-
men variables. Details of the SQ score calculation are de-
scribed in our previous study.11 In brief, this score was cal-
culated by base 10 logarithms multiplied by varying
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weights given to the 9 sperm parameters: concentration,
motility, sperm morphology according to WHO guidelines,
and Tygerberg strict criteria, VCL, VSL, VAP, LIN, and ALH.
The SQ score and ROS level comparisons between
groups were made using unpaired t tests, while correlations
between variables were assessed using Pearson’s correlation
coefficient. In addition, the sensitivity, specificity, positive
predictive value (PPV), and negative predictive value
(NPV) were also calculated. Receiver operating character-
istic (ROC) curves, such as the area under the curve (AUC),
were calculated to summarize the inherent capacity of the
sperm quality variables to discriminate patients with MFI
from the control donors. The SQ score along with ROS and
sperm parameters were compared using De Long’s
nonparametric comparisons.19 Calculations were performed
with GraphPad InStat version 3.00 statistical software
(GraphPad Software, Inc., San Diego, CA) and StatsDirect
(StatsDirect Ltd., Gresham Way, UK). A P value < .05 was
considered statistically significant.
RESULTS
Identification of MFI patients with SQ score
The SQ scores (mean ± standard deviation) for the do-
nors and patients are shown in Table 1. The SQ scores were
significantly higher in the donors than in the MFI patients
(P < .001). Significantly lower SQ scores were observed in
all groups of MFI patients compared with donors. The low-
est SQ score was seen in the patients with OAT.
In order to determine whether the SQ score could dif-
ferentiate MFI patients from control donors, we examined
various cutoff values to determine the SQ score that would
have the highest sensitivity. Table 2 displays various pre-
dictors of semen quality in 91 donors and 133 MFI patients
using different cutoff values of the SQ score. Using a cut-
off of 100 amongst the patient population, 93.23% (124 of
133) of men had a SQ score < 100, and only 7% (9 of 133)
of the patients had a SQ score > 100. At this cutoff, the sen-
sitivity was high (93.23%), and the PPV (or the probability
that a person having the disease given a positive test) was
70%, with an accuracy (defined as the positively diagnosed
MFI patients and correctly excluded donors) of 72%. The
specificity was, however, very low (40.65%) at this cutoff.
Lower cutoff values resulted in an increase in specificity
with a corresponding decrease in sensitivity.
A cutoff of ≤ 93.1 provided the optimum sensitivity of
80.45% and specificity of 70.32%. When a cutoff of ≤ 93.1
was used, the SQ score was able to correctly identify
80.45% of the patients as being MFI patients. Using this
cutoff, the overall accuracy in differentiating the donors
from the patients was 77% i.e. 150 of the 194 individuals
Table 1 - Reactive oxygen species (ROS) levels in donors and male factor infertility (MFI) patients and its correlation with
semen quality score
Study population SQ score P valuea ROS levels P valueb Correlation P valuec
coefficient
Donors 97.07 ± 10.76 (n = 91) - 1.20 ± 0.80d (n = 76) - - 0.45 < .001
MFI patients 75.56 ± 18.55 (n = 133) < .001 2.29 ± 1.05 (n = 121) < .001 - 0.36 < .001
Oligozoospermic 64.70 ± 14.93 (n = 61) < .001 2.70 ± 1.18 (n = 57) < .001 - 0.17 .20
Asthenozoospermic 70.55 ± 18.00 (n = 96) < .001 2.30 ± 1.10 (n = 90) < .001 - 0.39 .0002
Teratozoospermic 66.82 ± 16.50 (n = 69) < .001 2.40 ± 1.19 (n = 66) < .001 - 0.39 < .001
OAT 56.01 ± 12.69 (n = 38) < .001 2.82 ± 1.21 (n = 35) < .001 - 0.16 0.32
*Values are mean ± SD; OAT = oligoasthenoteratozoospermic; SQ = semen quality; aP < .05 was considered significant comparing SQ score
between donors and different groups of infertile patients; bP < .05 was considered significant comparing ROS levels between donors and
different groups of infertile population; cP < .05 was considered significant using Pearson correlation coefficient between SQ score and ROS
levels; dLog (ROS+1) were used
Table 2 - Identification of male factor infertility patients using prediction parameters with different cutoff values
Variable Cutoff value Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%)
SQ score cutoff
100 93.23 40.65 69.66 80.43 72
93.1 80.45 70.32 79.85 71.11 77
90 75.19 76.92 82.64 67.96 76
ROS levels
1 89.26 42.10 71.05 71.11 71
1.25 83.47 60.52 77.09 69.70 74.61
SQ = semen quality; ROS = reactive oxygen species; ROS values are log (ROS + 1); PPV = Positive predictive value; NPV = Negative predictive value
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in our study population could be correctly categorized with
this test (true positive and true negative).
Using an SQ score cutoff of ≤ 93.1, we compared SQ
score in this study population with normal sperm param-
eters with cutoff values established by WHO guidelines (2)
i.e. sperm concentration (≥ 20 x 106/mL), motility (≥ 50%)
and WHO morphology (≥ 30% normal forms) (Table 3). Mo-
tility showed a sensitivity of 72.18% and specificity of
83.51%. Using the WHO classification for sperm morphol-
ogy, the sensitivity was 51.87% and the specificity was
87.91%. On the other hand, Kruger’s morphology had sen-
sitivity of 82.70% but a very poor specificity (26.37%).
Identification of MFI patients using ROS levels
Significantly higher levels of ROS [log (ROS + 1)] were
seen within MFI patients, as well as in all the 4 subgroups,
compared to donors (P < .001) (Table 1). The highest lev-
els of ROS were seen in oligoasthenoteratozoospermic
(OAT) patients. A strong negative correlation was seen be-
tween the SQ score and levels of ROS for donors (r = - 0.45,
P < .001) and MFI patients (r = - 0.36, P < .001). A nega-
tive correlation was also seen in the asthenozoospermic and
teratozoospermic patients (Table 1). Using an ROS cutoff
of 1, the sensitivity was 89.26%, but the specificity in cor-
rectly identifying the infertile patients was poor (42.10%).
When the ROS cutoff was increased to 1.25, the sensitivity
decreased to 83.47%, but the specificity increased along
with accuracy (Table 1).
Receiver operating characteristic (ROC) curves
The effectiveness of the SQ score in differentiating the
MFI patients from the normal healthy donors was studied
by generating ROC curves (Table 4). Using a SQ score cut-
off of d” 93.1, the AUC was 84.28% with a 95% confidence
interval (CI) of 65.22% to 100%. The AUC using different
sperm parameters and ROS cutoff of 1.25 is shown in Table
4. Sperm concentration and percent motility had a similar
AUC. Both the AUC and 95% CI were much lower for sperm
morphology both by WHO criteria and Kruger’s strict cri-
teria (Fig. 1). The AUC for SQ score was higher (84.28%)
compared with that for ROS (78.92%) (Fig. 2).
We were also interested to see whether we could arrive
at the best cutoff values for sperm parameters in identify-
ing MFI patients compared to the well-established WHO
values for normal sperm parameters. By giving equal weight
to sensitivity and specificity, the best cutoff values were
provided by the statistical program. Using this method, a
significantly different cutoff value was obtained for sperm
concentration compared to the WHO cutoff value (Table 3).
Using a cutoff value of < 49.80 x 106/mL for sperm con-
centration, the best sensitivity (79.69%) was seen compared
to 45.86% at the WHO defined cutoff of < 20 x 106/mL.
Table 3 - Characteristics in correctly identifying the male factor infertility patients using calculated and World Health
Organization (WHO) established cutoff for various sperm parameters
Characteristic Cutoff value Sensitivity (%) Specificity (%) PPV NPV
Sperm count (X106/mL) < 20a 45.86 94.50 92.42 54.43
≤ 49.80b 79.69 71.42 80.30 70.65
Motility (%) < 50 a 72.18 83.51 86.48  67.25
≤ 50 b 74.43 81.31 85.34 68.51
Morphology (% normal forms)
  WHO morphology (%) < 30 a 51.87 87.91 86.25 55.55
≤ 29 b 51.87 87.91 86.25 55.55
  Kruger’s morphology (%) < 14 82.70 26.37 62.14 51.06
≤ 7 b 54.13 89.01 87.80 57.04
aWHO cutoff values; bCutoff values given by the statistical program; PPV = positive predictive value; NPV = negative predictive value
Table 4 - Areas under the curve (AUC) for semen quality (SQ) score and various sperm parameters
Variable Cutoff value AUC (%) 95% CI for AUC (%)
SQ cutoff score 93.1 84.28 65.22-100
Log (ROS+1) 1.25 78.92 72.60-85.23
Sperm count (x106/mL) a 20 81.31 63.62-99
Motility (%)a 50 82.29 64.13-100
Morphology (% normal forms)
 WHO morphology (%)a 30 68.16 56.20-80.12
 Kruger’s morphology (%) 14 70.39 57.57-83.21
WHO = World Health Organization; aCutoff values established by the WHO guidelines; ROS = reactive oxygen species; CI = confidence interval
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The cutoff values obtained by the statistical program for
both motility and sperm morphology, however, were simi-
lar (49.9% and 29%) to the WHO defined values of 50%
and 30%. These values were also comparable for sensitiv-
ity, specificity, positive predictive value, and negative pre-
dictive value. For sperm morphology by Kruger’s strict cri-
teria, a cutoff value of 7% had greater sensitivity and
specificity than a cutoff of 14% in correctly identifying the
MFI patients.
DISCUSSION
The role of traditional semen analysis and individual
sperm parameters in identifying fertile and infertile men is
a matter of ongoing debate. Several studies have reported
the predictive values of individual sperm parameters such
as concentration of motile spermatozoa20,21 and computer-
ized measurements of different patterns of spermatozoa mo-
tility22-24 and morphology25-28 to aid in the determination
of male fertility and infertility. There is no consensus within
the literature on the cutoff values of any individual param-
eter in defining patients with MFI from fertile males.29 It
appears that there is a need to establish a combined value
for all these sperm parameters (concentration, motility, and
morphology) into a single score that can explain semen
analysis results effectively and help establish the status of
the individual who comes to the infertility screening. This
approach would be helpful both to the clinician and the
patient.
Because a screening test is used to identify a maximum
number of patients during routine evaluation, the test must
be sensitive so that it can identify all true positives (number
of patients identified as being patients) at a given cutoff
point. Our results show that the SQ score was able to pre-
dict MFI patients with the best sensitivity (80.45%) along
with ROS (83.47%) at given cutoff points of 93.1 and 1.25,
respectively. All the sperm parameters had lower sensitivi-
ties in identifying the MFI patients when WHO-defined cut-
off points were used versus the SQ score and ROS.
Using the 10th percentile for the donors, we found that
the lower limit of normality for the SQ score was 84.38
while the upper limit (90th percentile) in MFI patients was
96.79. This indicates that only 10% (9 of 91) of the donors
have a score < 84.38 and that 11% of MFI patients (14 of
133) had an SQ score > 96.79. Overlapping of normal and
abnormal SQ scores between 2 groups is unavoidable us-
ing sperm parameters and SQ scores. Using a SQ cutoff score
of 93.1, only 12% (29/224) of our study population had
false positive results; that is, subjects who tested positive
but were actually negative. These individuals will, however,
be considered MFI patients. Similarly, by using this cutoff,
only 12% (26 of 224) of the patient population fell in the
category of normal healthy donors. Therefore, an SQ score
with a cutoff of 93.1 can better discriminate MFI patients
from normal, healthy donors. As a result, this cutoff can serve
as an effective screening tool during routine infertility evalu-
ation. Furthermore, using the AUC for the SQ score indi-
cated the probability of correctly identifying MFI patients
Figure 1 - Receiver operating characteristic curves showing the area
under the curve in male factor infertility patients and normal healthy
donors utilizing semen quality score and various parameters of sperm
quality: (A) semen quality score, (B) concentration, (C) motility, (D)
Kruger’s morphology, and (E) World Health Organization morphology
Figure 2 - Receiver operating characteristic curves showing the area
under curve in male factor infertility patients and normal healthy
donors using semen quality score and reactive oxygen species level
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and donors into their respective categories. The AUC for
SQ (84.28%) was better than the AUC for ROS (78.92%) and
other sperm parameters (Table 4). Sperm function tests like
the sperm penetration assay, sperm zona pellucida binding
assay,30 and acrosome reaction31 also correlate well with MFI
diagnosis and have a definite place in the evaluation of the
infertile male. However, because they are expensive and dif-
ficult to perform, they can be used only in specific circum-
stances or research settings but not as routine screening tests
in an andrology laboratory.
Sperm measurements that discriminate between fertile
and infertile men are not well defined.26, 29 Moreover, an ex-
tensive overlap was seen between the fertile and the infer-
tile men within both the subfertile and the fertile ranges
for all 3 measurements. We found that with current cutoff
values, sperm concentration and Kruger’s morphology
showed either poor sensitivity (45.86% for sperm concen-
tration) or poor specificity (26.37% for Kruger’s morphol-
ogy) in identifying MFI patients from normal healthy do-
nors. When sensitivity and specificity were weighted
equally, the best cutoff values provided by statistical pro-
gram for these parameters were significantly different from
current cutoff values (≤ 49.80 for sperm concentration and
≤ 7 for Kruger’s morphology).
Another interesting finding from our study was that, of
all the sperm parameters, sperm motility had the best sensi-
tivity and specificity at a WHO-defined cutoff point (sen-
sitivity of 72.18%, specificity of 83.51%) and was close to
the cutoff value derived by the statistical program.
Seminal ROS levels are a real concern because they are
potentially toxic to sperm quality and function at high lev-
els.32,33 Several studies reported that increased formation of
ROS is correlated with a reduction of sperm motility.34-36
Other studies failed to confirm these findings.37 Similarly,
several studies reported a correlation between sperm con-
centration and increased production of ROS in infertile pa-
tients,38-41 which other authors failed to confirm.37 In our
study, we found a significant correlation between the SQ
score derived from sperm parameters and ROS levels in all
the MFI patients. The correlation increased as the amount
of abnormal spermatozoa increased and motility decreased
(Table 1).
An important implication of our study is that the SQ score
was developed from individual sperm parameters. Therefore,
this score provides us with an overall indicator of spermato-
zoa quality in any given semen sample, which may not be
appreciated by examining a single parameter. In addition, the
production of ROS depends on the overall quality of the sper-
matozoa in a given semen sample and not on any individual
sperm parameter. This explains the good correlation between
SQ scores and ROS levels. Since the production of ROS de-
pends on the overall quality of semen, we used ROS levels
to discriminate donors and MFI patients. The clinical sig-
nificance of our study lies in identifying parameters that ac-
curately differentiate infertile male patients.
The main limitation of our study was that it was retro-
spective in nature. In addition, we did not have proven fer-
tile donors to use as controls; consequently, we used nor-
mal healthy donors instead. These donors were selected
based on the fact that they did not present to our male in-
fertility clinic. However, not all of the donors exhibited nor-
mal semen characteristics defined by WHO guidelines for
normal, healthy donors. A prospective study using proven
fertile donors is needed to evaluate the efficacy of the SQ
score and ROS levels as new tools in screening for male
factor infertility.
In conclusion, our study demonstrates that the SQ score
and ROS levels are highly correlated with MFI and are bet-
ter discriminators of MFI than individual sperm parameters.
Both of these parameters show better sensitivity than the
individual sperm parameters in identifying infertile patients
and should be included in routine infertility screening.
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RESUMO
Nallella KP, Sharma RK, Allamaneni SSR, Agarwal A. Iden-
tificação de pacientes portadores do fator de infertilidade
masculina através do cálculo de um novo escore de quali-
dade de sêmen e pela medida de espécies reativas de oxi-
gênio. Clinics. 2005:60(4):317-24.
OBJETIVO: Determinar se pacientes portadores do fator
de infertilidade masculina podem ser precisamente identi-
ficados através do cálculo de um novo escore de qualidade
de sêmen e pela medida de espécies reativas de oxigênio
durante uma avaliação rotineira de infertilidade.
MÉTODOS: Amostras de sêmen de 133 pacientes e de 91
doadores saudáveis foram avaliadas através de análise ma-
nual e computadorizada de sêmen. Um modelo de análise
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do componente principal foi empregado para calcular o es-
core de qualidade de sêmen, utilizando logaritmos base 10,
multiplicados por ponderações variáveis de 9 parâmetros
espermáticos. Os níveis de espécies reativas de oxigênio fo-
ram medidos através de testes de quimiluminescência.
RESULTADOS: O escore de qualidade de sêmen apresen-
tou sensibilidade de 80.45% e precisão de 77% para um
“cutoff” de 93.1 na identificação do fator de infertilidade
masculina. A área sob a curva “receiver operating
characteristic” para o escore de qualidade de sêmen foi de
84.28% (95% intervalo de confiança: 65.22%-100%). Os
níveis de espécies reativas de oxigênio [log10 (espécies
reativas de oxigênio +1)] foram siginificativamente mais
elevados nos pacientes portadores de fator de infertilidade
masculina. A medica de espécies reativas de oxigênio apre-
sentou sensibilidade de 83.47% e especificidade de 60.52%
com uma precisão (definida como pacientes portadores do
fator de infertilidade masculina com diagnóstico positivo
e doadores corretamente excluídos) de 75% para um
“cutoff” de 1.25 na identificação de pacientes portadores
do fator de infertilidade masculina. A área sob a curva
“receiver operating characteristic” para níveis de espécies
reativas de oxigênio foi de 78.92% (95% intervalo de con-
fiança: 72.60%-85.23%). Os escores de qualidade de sêmen
correlacionaram negativamente com os níveis de espécies
reativas de oxigênio tanto nos doadores e nos pacientes por-
tadores do fator de infertilidade masculina.
CONCLUSÕES: O escore de qualidade de sêmen e os ní-
veis espécies reativas de oxigênio nas amostras de sêmen pa-
recem associar-se fortemente com o fator de infertilidade
masculina. Na medida em que os dois parâmetros mostraram-
se mais sensíveis que parâmetros espermáticos individuais
na identificação do fator de infertilidade masculina, deveri-
am ser incluídos na avaliação rotineira de infertilidade.
UNITERMOS: Espermatozóide. Fator de infertilidade
masculina. Escores de qualidade de sêmen. Espécies
reativas de oxigênio. Parâmetros espermáticos.
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